Drugs with anti-oxidant properties can interfere with cell viability measurements by assays that rely on the reducing property of viable cells

Niraj Shenoy, Mary Stenson, Joshua Lawson, Jithma Abeykoon, Mrinal Patnaik, Xiaosheng Wu, Thomas Witzig

Research output: Contribution to journalArticle

4 Citations (Scopus)

Abstract

Cell viability assays such as Cell Titer Blue and Alamar Blue rely on the reducing property of viable cells to reduce the reagent dye to a product which gives a fluorescent signal. The current manufacture-recommended protocols do not take into account the possibility of the reagent substrate being reduced directly to the fluorescent product by drugs with an anti-oxidant property. After suspecting spurious results while determining the cytotoxic potential of a drug of interest (DOI) with known anti-oxidant property against a renal cell cancer (RCC) cell line, we aimed to establish that drugs with anti-oxidant property can indeed cause false-negative results with the current protocols of these assays by direct reduction of the reagent substrate. We also aimed to counter the same with a simple modification added to the protocol. Through our experiments, we conclusively demonstrate that drugs with anti-oxidant properties can indeed interfere with cell viability measurements by assays that rely on the reducing property of viable cells. A simple modification in the protocol, as elaborated in the manuscript, can prevent spurious results with these otherwise convenient assays.

Original languageEnglish (US)
Pages (from-to)494-497
Number of pages4
JournalLaboratory Investigation
Volume97
Issue number5
DOIs
StatePublished - May 1 2017
Externally publishedYes

Fingerprint

Oxidants
Cell Survival
Pharmaceutical Preparations
Manuscripts
Renal Cell Carcinoma
Coloring Agents
Cell Line

ASJC Scopus subject areas

  • Pathology and Forensic Medicine
  • Molecular Biology
  • Cell Biology

Cite this

Drugs with anti-oxidant properties can interfere with cell viability measurements by assays that rely on the reducing property of viable cells. / Shenoy, Niraj; Stenson, Mary; Lawson, Joshua; Abeykoon, Jithma; Patnaik, Mrinal; Wu, Xiaosheng; Witzig, Thomas.

In: Laboratory Investigation, Vol. 97, No. 5, 01.05.2017, p. 494-497.

Research output: Contribution to journalArticle

Shenoy, Niraj ; Stenson, Mary ; Lawson, Joshua ; Abeykoon, Jithma ; Patnaik, Mrinal ; Wu, Xiaosheng ; Witzig, Thomas. / Drugs with anti-oxidant properties can interfere with cell viability measurements by assays that rely on the reducing property of viable cells. In: Laboratory Investigation. 2017 ; Vol. 97, No. 5. pp. 494-497.
@article{9e86fbc53ffd4a239af9ecdde240c889,
title = "Drugs with anti-oxidant properties can interfere with cell viability measurements by assays that rely on the reducing property of viable cells",
abstract = "Cell viability assays such as Cell Titer Blue and Alamar Blue rely on the reducing property of viable cells to reduce the reagent dye to a product which gives a fluorescent signal. The current manufacture-recommended protocols do not take into account the possibility of the reagent substrate being reduced directly to the fluorescent product by drugs with an anti-oxidant property. After suspecting spurious results while determining the cytotoxic potential of a drug of interest (DOI) with known anti-oxidant property against a renal cell cancer (RCC) cell line, we aimed to establish that drugs with anti-oxidant property can indeed cause false-negative results with the current protocols of these assays by direct reduction of the reagent substrate. We also aimed to counter the same with a simple modification added to the protocol. Through our experiments, we conclusively demonstrate that drugs with anti-oxidant properties can indeed interfere with cell viability measurements by assays that rely on the reducing property of viable cells. A simple modification in the protocol, as elaborated in the manuscript, can prevent spurious results with these otherwise convenient assays.",
author = "Niraj Shenoy and Mary Stenson and Joshua Lawson and Jithma Abeykoon and Mrinal Patnaik and Xiaosheng Wu and Thomas Witzig",
year = "2017",
month = "5",
day = "1",
doi = "10.1038/labinvest.2017.18",
language = "English (US)",
volume = "97",
pages = "494--497",
journal = "Laboratory Investigation",
issn = "0023-6837",
publisher = "Nature Publishing Group",
number = "5",

}

TY - JOUR

T1 - Drugs with anti-oxidant properties can interfere with cell viability measurements by assays that rely on the reducing property of viable cells

AU - Shenoy, Niraj

AU - Stenson, Mary

AU - Lawson, Joshua

AU - Abeykoon, Jithma

AU - Patnaik, Mrinal

AU - Wu, Xiaosheng

AU - Witzig, Thomas

PY - 2017/5/1

Y1 - 2017/5/1

N2 - Cell viability assays such as Cell Titer Blue and Alamar Blue rely on the reducing property of viable cells to reduce the reagent dye to a product which gives a fluorescent signal. The current manufacture-recommended protocols do not take into account the possibility of the reagent substrate being reduced directly to the fluorescent product by drugs with an anti-oxidant property. After suspecting spurious results while determining the cytotoxic potential of a drug of interest (DOI) with known anti-oxidant property against a renal cell cancer (RCC) cell line, we aimed to establish that drugs with anti-oxidant property can indeed cause false-negative results with the current protocols of these assays by direct reduction of the reagent substrate. We also aimed to counter the same with a simple modification added to the protocol. Through our experiments, we conclusively demonstrate that drugs with anti-oxidant properties can indeed interfere with cell viability measurements by assays that rely on the reducing property of viable cells. A simple modification in the protocol, as elaborated in the manuscript, can prevent spurious results with these otherwise convenient assays.

AB - Cell viability assays such as Cell Titer Blue and Alamar Blue rely on the reducing property of viable cells to reduce the reagent dye to a product which gives a fluorescent signal. The current manufacture-recommended protocols do not take into account the possibility of the reagent substrate being reduced directly to the fluorescent product by drugs with an anti-oxidant property. After suspecting spurious results while determining the cytotoxic potential of a drug of interest (DOI) with known anti-oxidant property against a renal cell cancer (RCC) cell line, we aimed to establish that drugs with anti-oxidant property can indeed cause false-negative results with the current protocols of these assays by direct reduction of the reagent substrate. We also aimed to counter the same with a simple modification added to the protocol. Through our experiments, we conclusively demonstrate that drugs with anti-oxidant properties can indeed interfere with cell viability measurements by assays that rely on the reducing property of viable cells. A simple modification in the protocol, as elaborated in the manuscript, can prevent spurious results with these otherwise convenient assays.

UR - http://www.scopus.com/inward/record.url?scp=85019557183&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85019557183&partnerID=8YFLogxK

U2 - 10.1038/labinvest.2017.18

DO - 10.1038/labinvest.2017.18

M3 - Article

AN - SCOPUS:85019557183

VL - 97

SP - 494

EP - 497

JO - Laboratory Investigation

JF - Laboratory Investigation

SN - 0023-6837

IS - 5

ER -